Cargando…
Humoral hypercalcemia of pregnancy treated with bisphosphonates
Hypercalcemia can be hazardous during pregnancy, most cases being due to primary hyperparathyroidism. We report a case of hypercalcemia with suppressed PTH levels necessitating treatment with bisphosphonates during pregnancy. A 38-year-old woman at the 26(th) week gestation was admitted because of s...
Autores principales: | Koren, Ronit, Neeman, Ortal, Koren, Shlomit, Benbassat, Carlos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118686/ https://www.ncbi.nlm.nih.gov/pubmed/29694631 http://dx.doi.org/10.20945/2359-3997000000016 |
Ejemplares similares
-
Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
por: Koren, Ronit, et al.
Publicado: (2021) -
Denosumab-Induced Rebound Hypercalcemia Treated With Bisphosphonates in a Pediatric Patient
por: Gandolfi, Anne, et al.
Publicado: (2023) -
Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia
por: Kilinc, Suna, et al.
Publicado: (2020) -
Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
por: Lim, Seungtaek, et al.
Publicado: (2013) -
Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)